Cost-Effectiveness of a Combination of Renin-Angiotensin System Inhibitors (Ras)/Calcium Channel Blockers (Ccb) or Ras Monotherapy to Retard Progression of Kidney Disease in Malaysia
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.501
https://www.valueinhealthjournal.com/article/S1098-3015(16)31081-6/fulltext
Title :
Cost-Effectiveness of a Combination of Renin-Angiotensin System Inhibitors (Ras)/Calcium Channel Blockers (Ccb) or Ras Monotherapy to Retard Progression of Kidney Disease in Malaysia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31081-6&doi=10.1016/j.jval.2016.08.501
First page :
A847
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2504